Tandem Diabetes Care (TNDM) Other Accumulated Expenses (2013 - 2026)

Tandem Diabetes Care's Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $84.1 million for Q1 2026.

• Quarterly Other Accumulated Expenses fell 8.4% year-over-year to $84.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.1 million (down 8.4% YoY) and the FY2025 annual result came in at $75.2 million, up 52.57% from the prior year.
• Other Accumulated Expenses was $84.1 million for Q1 2026 at Tandem Diabetes Care, up from $75.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $100.0 million in Q2 2025 and bottomed at $22.9 million in Q1 2022.
• A 5-year average of $48.7 million and a median of $33.9 million in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2025 — Other Accumulated Expenses jumped 202.63% — and 2026, when it decreased 8.4%.
• Tandem Diabetes Care's Other Accumulated Expenses stood at $29.3 million in 2022, then declined by 2.94% to $28.5 million in 2023, then jumped by 73.26% to $49.3 million in 2024, then jumped by 52.57% to $75.2 million in 2025, then advanced by 11.78% to $84.1 million in 2026.
• Business Quant data shows TNDM's Other Accumulated Expenses at $84.1 million in Q1 2026, $75.2 million in Q4 2025, and $96.9 million in Q3 2025.